NIH-CSR <script type="text/javascript"> var wmNotice = "UNT Web Archive - External links, forms, and search boxes may not function within this collection. Url: http://cms.csr.nih.gov/PeerReviewMeetings/CSRIRGDescription/IDMIRG/IDM11.htm time: 15:40:33 Sep 20, 2008"; var wmHideNotice = "hide"; var contextRoot = "https://webarchive.library.unt.edu/eot2008/"; </script> <script type="text/javascript" src="https://webarchive.library.unt.edu/eot2008/js/disclaim.js"></script> <span id="Postingname3_PostingDisplayName">Small Business: Bacterial Biodefense Agents Special Emphasis Panel [IDM (11)]</span> (IDMIRG)


search

Small Business: Bacterial Biodefense Agents Special Emphasis Panel [IDM (11)]

The Small Business: Bacterial Biodense Agents Special Emphasis Panel [IDM (11)] considers SBIR and STTR applications focused on bacterial biodefense agents and their toxins. Topics may include molecular- and bioengineering-based technologies, including biosensors, for the development of detection methods, diagnostics, and therapeutics.

Specific areas covered by IDM (11):

Development of bacterial detection and diagnostic tools.
Development of novel antibiotics or anti-infective agents and animal models for efficacy studies.
Development of novel therapeutic processes or interventions to combat bacterial biodefense-related infections

IDM (11) has the following shared interests within the IDM IRG:

With Small Business: Bacterial Diseases, Food Safety and General Microbiology [IDM (10)]: Studies that focus on drug therapies or detection technologies for bacterial agents including food and water borne pathogens could be assigned to IDM (10). Studies to develop detection technologies or drug discovery for bacterial biodefense agents and their toxins could be assigned to IDM (11).

IDM (11) has the following shared interests outside the IDM IRG:

With the Biological Chemistry and Macroomolecular Biophysics [BCMB] IRG: Applications that involve biochemical pathways or medicinal chemistry as they relate to the development of antibiotics, diagnostics, drug manufacturing or delivery could be assigned to IDM (11) if the research focuses on the bacterial biodefense agents and their toxins. Those applications that focus on the chemical aspects of these processes could be assigned to BCMB.
With the Genes, Genomes and Genetics [GGG] IRG: Applications that utilize molecular genetics techniques for drug or diagnostic development could be assigned to IDM (11), if the focus of the work is on the bacterial biodefense agents and their toxins. Studies in which the results will be broadly applicable across kingdoms (i.e., crosscutting studies) could be assigned to GGG.
With the Bioengineering Sciences and Technologies [BST] IRG: Applications proposing development and validation of methods focusing on bacterial biodefense agents and their toxins detection, diagnostic and therapeutic may be assigned to IDM (11). Applications that focus on drug delivery, when the purpose is treatment of infections acquired by bacterial biodefense agents and their toxins are appropriate for the IDM (11). General development of novel gene and drug delivery technologies may be assigned to the BST IRG.
With the Immunology [IMM] IRG: Applications focused on the immune response to bacterial infection could be assigned to IMM. Those applications focused on bacterial biodefense agents that utilize immunological reagents (i.e. antibodies) as a therapeutic agent or diagnostic tool, or those in which the immune response is not the primary focus, could be assigned to IDM (11).